Asia-Pacific Iron-Deficiency Anemia Therapy Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Mar 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 54
  • No of Figures: 31

Iron-Deficiency Anemia Therapy Market, By Therapy (Parenteral Iron Therapy and Oral Iron Therapy), Therapy Areas (Inflammatory Bowel Disease, Renal, Obstetrics and Gynecology, Congestive Heart Failure (CHF), Oncology and Others), Population (Adults, Pediatric and Geriatric), Country (Japan, China, Australia, South Korea), Market Trends and Forecast to 2027. 

Asia-Pacific Iron-Deficiency Anemia Therapy Market

Market Analysis and Insights: Asia-Pacific Iron-Deficiency Anemia Therapy Market

Iron-deficiency anemia therapy market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 17.9% in the forecast period of 2020 to 2027 and expected to reach USD 1,118.46 million by 2027. Growing prevalence of iron deficiency anemia and launch of the novel therapies is a driving factor for the market growth.

Rising cases of haemodilation is due to the lifestyle changes for instance, consumption of alcohol, lack of exercise, smoking and fast food among more resulting in hormonal imbalance, irregular BMI and increased weight leads to change in the physiology of woman in pregnancy.

During pregnancy, hemodilution events are considered positive because they improve blood flow and improve the supply of nutrients and oxygen to the brain. Thus, during pregnancy, there are an increasing number of events of haemodiltuion, which acts as a driving force for the growth of the iron deficiency anemia market.

This Iron-Deficiency Anemia Therapy Market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Iron-Deficiency Anemia Therapy Market

Asia-Pacific Iron-Deficiency Anemia Therapy Market Scope and Market Size

Asia-Pacific iron-deficiency anemia therapy market is segmented on the basis of basis of therapy, therapy areas, and population. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of therapy, the market is segmented into oral iron therapy and parenteral iron therapy. In 2020, the iron oral therapy sector maintains a significant market share and will also grow at a higher rate during the forecasted period as oral treatment is generally preferred for iron deficiency treatment and parental iron treatment is usually given to patients who cannot absorb iron orally or are diagnosis of increased anemia even after adequate intake of iron supplements orally.
  • On the basis of therapy areas, the market is segmented into inflammatory bowel disease, congestive heart failure (CHF), oncology, obstetrics and gynecology, renal and others. In 2020, inflammatory bowel sector maintains a significant market share and will also grow at a higher rate during the forecasted period of the Asia-Pacific market for the treatment of iron-deficiency anemia, with a third of IBD patients suffering from persistent anemia. Anemia is a common manifestation of IBD and is often overlooked as complications. Iron deficiency anemia (IDA) is most common in IBD patients, which is due to chronic blood loss and poor iron absorption due to tissue inflammation.
  • On the basis of population, the market is segmented into geriatric, adults and pediatric. In 2020, Adult segments gain prominence in the Asia-Pacific iron deficiency anemia therapy market due to pre-natal period and due to the reduction of body to menstrual fluid.

 Iron-Deficiency Anemia Therapy Market Country Level Analysis

Iron-deficiency anemia therapy market is analysed and market size information is provided by country, basis of therapy, therapy areas, and population as referenced above.

The countries covered in iron-deficiency anemia therapy market report are Japan, China, South Korea, and Australia in the Asia-Pacific. Japan is leading the growth of the Asia-Pacific market due to health infrastructure, improvement of insurance payers, economic growth, expansion and development of the private health sector and raise awareness among people.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Incidences of Iron Deficiency Anemia in the Region

Iron-deficiency anemia therapy market also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in iron-deficiency anemia therapy and changes in regulatory scenarios with their support for the iron-deficiency anemia therapy market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Iron-Deficiency Anemia Therapy Market Share Analysis

Iron-deficiency anemia therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Asia-Pacific iron-deficiency anemia therapy market.

The major players covered in the report are Vifor Pharma Ltd., Lupin, CHO-A PHARM.CO.,LTD,., FRESENIUS SE & CO. KGAA, Sanofi, Novartis AG, AbbVie Inc., Orion Corporation, Advanz Pharmaceutical, GlaxoSmithKline plc., Alkem Labs, Hikma Pharmaceuticals PLC players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of Iron-deficiency anemia therapy market.

For instance,

  • In July 2019, Vifor Pharma Ltd. announced that a drug for ferrinject, an iron deficiency anemia, will be launched in Japan by the end of 2019 and will be eligible for reimbursement. This measure by Vifor Pharma Ltd. has increased its credibility in the market, and as the market expands, sales and revenue will increase in the future.

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for iron-deficiency anemia therapy market through expanded range of size.

Customization Available: Asia-Pacific Iron-Deficiency Anemia Therapy Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 PREVALENCE OF ANEMIA AMONG WOMEN OF REPRODUCTIVE AGE (% OF WOMEN AGES 15-49), (2013-2016)

TABLE 2 ASIA PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, PIPELINE ANALYSIS

TABLE 3 ASIA PACIFIC AND WHO REGIONAL MEAN BLOOD HAEMOGLOBIN CONCENTRATION AND PREVALENCE OF ANAEMIA BY POPULATION GROUP FOR 2011

TABLE 4 PREVALENCE OF ANEMIA IN CHILDREN OF AFRICA AND ASIA

TABLE 5 IRON DEFICIENCY ANEMIA THERAPEUTICS R&D ACTIVITIES

TABLE 6 CAUSES, PREVALENCE, AND CLINICAL CONSEQUENCES OF IRON DEFICIENCY IN INFLAMMATORY CONDITIONS

TABLE 7 ASIA PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 8 ASIA PACIFIC ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 ASIA PACIFIC ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 10 ASIA PACIFIC PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 ASIA PACIFIC PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 12 ASIA PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 13 ASIA PACIFIC INFLAMMATORY BOWEL DISEASE IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 ASIA PACIFIC RENAL IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 ASIA PACIFIC RENAL IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 16 ASIA PACIFIC OBSTETRICS AND GYNECOLOGY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 ASIA PACIFIC CONGESTIVE HEART FAILURE (CHF) IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 ASIA PACIFIC ONCOLOGY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 ASIA PACIFIC OTHERS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 ASIA PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2018-2027 (USD MILLION)

TABLE 21 ASIA PACIFIC ADULTS IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 ASIA PACIFIC PEDIATRIC IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 ASIA PACIFIC GERIATRIC IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 25 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 26 ASIA-PACIFIC ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 27 ASIA-PACIFIC PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC RENAL IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2018-2027 (USD MILLION)

TABLE 31 JAPAN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 32 JAPAN ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 33 JAPAN PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 34 JAPAN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 35 JAPAN RENAL IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 36 JAPAN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2018-2027 (USD MILLION)

TABLE 37 CHINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 38 CHINA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 39 CHINA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 40 CHINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 41 CHINA RENAL IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 42 CHINA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2018-2027 (USD MILLION)

TABLE 43 AUSTRALIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 44 AUSTRALIA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 45 AUSTRALIA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 46 AUSTRALIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 47 AUSTRALIA RENAL IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 48 AUSTRALIA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2018-2027 (USD MILLION)

TABLE 49 SOUTH KOREA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 50 SOUTH KOREA ORAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 51 SOUTH KOREA PARENTERAL IRON THERAPY IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY, 2018-2027 (USD MILLION)

TABLE 52 SOUTH KOREA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 53 SOUTH KOREA RENAL IN IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY THERAPY AREAS, 2018-2027 (USD MILLION)

TABLE 54 SOUTH KOREA IRON-DEFICIENCY ANEMIA THERAPY MARKET, BY POPULATION, 2018-2027 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions